Translational leakiness (i.e., nonspecific suppression) of nonsense mutants of bacteriophage T4 is increased in cells of certain streptomycin-resistant strains previously grown in the presence of streptomycin. Con Under controlled conditions, streptomycin binds directly and specifically to naked 16S RNA, whatever its origin, and the drug's failure to bind to 30S subunits derived from streptomycin-resistant cells is apparently due to a masking of the 16S specific site(s) by the mutated S12 protein (1). Moreover, 16S RNA bound to streptomycin fails to reconstitute in vitro biologically active 30S subunits. Obviously a similar total failure to assemble active ribosomes does not occur in vivo since streptomycin-resistant strains grow normally in the presence of streptomycin. It is possible, however, that the drug might be able to interfere in a limited way with the proper assembly, resulting in functionally altered ribosomes.
read accumulate with kinetics expected for a constant differential rate of synthesis of a new product induced by drug action. The misreading ribosomes do not contain appreciable amounts of streptomycin and the misreading property is lost by exposure to high salt concentrations. It is suggested that streptomycin (or dihydrostreptomycin, or paromomycin) induces a reversible modification in 30S subunit assembly without physically participating in the modified structure. The extent of this modification appears dependent upon the strA allele.
Under controlled conditions, streptomycin binds directly and specifically to naked 16S RNA, whatever its origin, and the drug's failure to bind to 30S subunits derived from streptomycin-resistant cells is apparently due to a masking of the 16S specific site(s) by the mutated S12 protein (1) . Moreover, 16S RNA bound to streptomycin fails to reconstitute in vitro biologically active 30S subunits. Obviously a similar total failure to assemble active ribosomes does not occur in vivo since streptomycin-resistant strains grow normally in the presence of streptomycin. It is possible, however, that the drug might be able to interfere in a limited way with the proper assembly, resulting in functionally altered ribosomes.
With these considerations in mind, we have now reexamined an unpublished observation of some years ago, which we were unable to explain at that time. In studying phenotypic suppression of T4 nonsense mutants, we observed that streptomycin programs the suppression ability of a strA40 host cell before suppression actually occurs. It may be noted that such a mechanism is not peculiar to phage infection, but that it becomes evident only with phage because it is possible to separate operationally host programming during growth before infection from actual suppression, which occurs during phage propagation.
Our investigation suggests that streptomycin does indeed interfere with normal ribosomal assembly when a responsive S12 mutation is present in the genome and, as a result of this interference, a functionally altered ribosomal particle is assembled. STRAINS (C410, C427) T4 mutants. In the samples presented in the table, the programming effect is about 10-times greater than the effect on propagation and this latter effect occurs relatively independently from the previous programming. Clearly the mechanisms underlying the two effects are different and the possibility is excluded that the programming effect may consist of a misinterpretation of a trivial artifact due to unbound streptomycin not completely washed away. Both streptomycin effects are exerted exclusively on translational leakiness of nonsense mutants because growth of wild-type phage is indifferent to host pregrowth in streptomycin and to the presence of the drug during phage propagation. The type of strA mutation carried in the ribosomes of the host strain plays an essential role in both these streptomycin effects. In fact, of the two strA mutants resistant to streptomycin tested, strA40 responds to streptomycin while strAl appears indifferent to the drug. This correlates with the known difference in ability to restrict suppression displayed by these two strA alleles, strA40 being less restrictive than strAl (2) . Finally, results similar to those presented in Table 1 are T4 bacteriophage strains: N65 and cwAl are UGA mutants within and outside the nI region, respectively. E. coli B sustrains: Li strA4O and Li strAl are transductants of either strA allele into the same parent. Phage N65 was tested by use of Xlysogen hosts. Both lysogen and nonlysogen were used with the same results for testing of cAl. Growth conditions before infection: at 300 in medium L containing 0 or 100 ,ug/ml of streptomycin. Overnight cultures were diluted in fresh medium, brought to logarithmic phase again, and stopped when a density of 2 X 108 cells per ml was reached. The cells were centrifuged and washed three times with A-N buffer, then suspended at 2 X 109 cells per ml in medium L containing 0 or 100 ,Ag of streptomycin per ml. Phage infection is done at 300 with a multiplicity of infection of 0.01 (i.e., 107 input phage). The figures are the number of phages found at 60 min less those found unadsorbed at 7 min after infection. The titer of these unadsorbed phages, determined in each sample, was consistently the same (i.e., no effect of streptomycin or pregrowth on phage adsorption) and thus averaged. Wild-type T4 gives similar burst sizes with both hosts and under all conditions tested and are therefore averaged. The same can be said for T4 mutants N65 and coAl tested with Li strAl. The table presents the results of a single set of experiments, but five were performed. In spite of significant fluctuations between the different sets, they show unequivocally an identical general pattern. Sm, streptomycin.
* Phage burst size X 10-2.
obtained by testing dihydrostreptomycin instead of streptomycin. Moreover, by use of a host strain carrying a strA allele that confers resistance to both paromomycin and streptomycin, the effects of streptomycin and of paromomycin can be compared. It is found that the effects of the two drugs are identical in pat t ern and very similar in amount. The experiments presented in Figs Fwo. 1 . Kinetics by which suppression of efficiency of Li strA40 increases during growth in streptomycin or dihydrostreptomycin. Suppression by Li strA40 was tested on T4 mutants C410 ochre (left) and N65 UGA (right). Host pregrowth and phage propagation were at 300 in medium L. Streptomycin or dihydrostreptomycin were present for different times during host pregrowth, but were absent during phage propagation. Different volumes of inoculum, withdrawn from an exponentiaily growing culture reaching OD of 1.5 of Li strA40 (or of its X-lysogen when N65 is tested), were quickly diluted in different volumes of warmed medium L, each containing the amount of drug needed for a final concentration of 100 ,g/mi. All subcultures (7 ml total volume each) were harvested when the same OD of 1.5 was reached again, so that each culture went through a different, preestablished number of cell divisions, but all cells were exactly in the same phase of growth at the moment of phage infection. As a control, the incubation time needed by each subculture to reach OD 1.5 was checked and found to be, as expected, the division time (30 min) multiplied by the preestablished number of divisions. Samples of the original undiluted culture were immediately chilled to 00 and, after addition of the drug, kept in ice throughout the incubation. Zero-time samples with and without the drug were also examined. At the end of the incubation the cells were centrifuged at 00, washed three times with A-N buffer, suspended in L medium at 2 X 10' cells per ml (a 10-times concentration of the centrifuged culture), and infected at a multiplicity of infection of 0.01. The burst size was determined (see details in footnotes of Table 1 shown already (2), and Table 1 reiterates, that strA mutations control translational leakiness and suppression. Thus the programming cited above should consist of some alteration occurring in the 30S ribosomal subunits and caused by the presence of the drug. The controls of the experiment presented in Fig. 1 show that cells to which streptomycin or dihydrostreptomycin had been added after they were cooled to 0°, then centrifuged and washed immediately, or after maintenance at 00 (i.e., in nongrowing conditions) for a time corresponding to 5 generations if they were incubated at 30°, display the same suppression efficiency as cells grown in the absence of the drug (for example the average burst size of N65 is 0.05 phage per adsorbed input phage). By contrast, after 5 generations in the presence of streptomycin (or dihydrostreptomycin) the suppression efficiency rises about 80 times (burst size of N65 is four phage per adsorbed input phage). This finding indicates that growth is required for production of the supposed 30S modification. On the assumption that the 30S subunits assembled after addition of streptomycin are the only ones responsible for the high suppression efficiency, the rate of increase in suppression should follow the usual (6) satisfy the hypothesis. The kinetics obtained with UGA N65 (and with coA1, not shown) could be accounted for by suggesting that phage growth is less than proportional to the min. The clear supernatants were centrifuged at 50,000 rpm (170,000 X g) for 120 min. The supernatant was removed and the pellets were dissolved in small amounts (0.3 ml) of N+ buffer. These solutions were centrifuged at 15,000 rpm (15,000 X g) for 15 min. Genetics: Garvin et al.
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function corrected, while with ochre C427 (also not shown) the growth should be more than proportional. Whatever the explanation is for the observed departures from theoretical expectations, the important point is that all cases exclude an immediate uptake of the drug. The results reported so far are only an indication that one of the targets of streptomycin action in vivo might be the assembly of 30S subunits, but more direct evidence of this is given by the study of extracted ribosomes described below. According to previous knowledge (2) , if it is correct that growth in the presence of the drug brings about a structural modification of the ribosomes responsible for the observed enhancement of nonsense leakiness, then the same modified ribosomes should also permit a higher level of misreading in vitro. The amount of this misreading is expected to be very modest because it should not interfere in vivo with cellular growth since the growth of Li strA4O is not slowed in the presence of the drug. Moreover, the misreading should be intrinsic to the system, in the sense that it should occur in the absence of added streptomycin since enhancement of suppression is seen after growth in streptomycin but the drug need not necessarily be present when suppression actually occurs. Finally, misreading should be seen only with ribosomes extracted from Li strA40 and L190 grown in the presence of streptomycin (or dihydrostreptomycin or paromomycin), but it should be undetectable or very low with ribosomes from the same strains grown in the absence of the drug or from L1 strA l grown under either condition.
Initially, several experiments were performed with Li strA40 ribosomes extracted and purified with a technique involving exposure to high salt concentration. The results failed to show any difference in misreading between cells grown in the presence and in the absence of streptomycin.
Subsequently, the possibility was considered that the sought ribosomal alteration might be reversible in high salt concentration, as observed already in a study involving L190 ribosomes (8) . The step of ribosomal pelleting through a sucrose gradient in a buffer containing 1 M ammonium chloride was therefore eliminated (see description of the technique actually used in the footnote to Table 2 ). The ribosomes extracted with this modified technique from Li strA40 grown in the presence of streptomycin now permitted misreading (Table 2) .
By contrast the ribosomes from Li strA40 grown without streptomycin or from Li strAl grown under either condition failed to show any appreciable misreading. Moreover, upon subsequent treatment with the sucrose-gradient step previously omitted, the misreading ribosomes lost this property.
Thus, growth in the presence of streptomycin brings about a reversible ribosomal modification, responsible for enhancement of unspecific suppression (i.e., nonsense leakiness) in vivo and of misreading in vitro. Table 2 shows the kinetics by which the amount of misreading per unit of ribosome increases as a function of growth in the presence of the drug (in this particular case, dihydrostreptomycin). Similar to the suppression-efficiency increase (see C410 in Figs. 1 and 2) , the kinetics of increase of misreading are compatible with the assumption that the modified ribosomes (= drug-ribosomes) are formed and accumulate at a constant rate during exponential growth in the presence of the drug. A second point concerns the role of protein S12 in the architecture and functioning of 30S subunits. Originally S12, which is determined by the gene strA where the streptomycinresistant mutations are located, was considered to be the site of action of streptomycin and therefore directly related to the bactericidal action of streptomycin. This concept, however, became untenable: first, when mutants resistant to streptomycin and/or paromomycin were isolated and shown to be located at the same strA site (5); and second, when mutation ram (the gene of protein S4) was isolated and studied (7) . It was then discovered that S12 and S4 interact inside the 30S subunit structure in such a way that the first restricts and the second relaxes the ribosomal function of securing fidelity in translation. Accordingly, strA was considered to be the site of without physically participating in the new structure. It is Proc. Nat. Acad. Sci. USA 70 (1978) ribosomal restriction and streptomycin, whose action formally mimicked that of ram, was supposed to antagonize restriction by modifying, in analogy to ram, the structural relationship of S12 with the rest of the ribosomal architecture. This rather vague model is now supported by the present discovery indicating that streptomycin interferes with ribosomal assembly, even conceding that ribosomal assembly is not the only target of streptomycin action, since Table 1 shows an additional effect on suppression efficiency, independent from assembly.
In terms of streptomycin binding, the strAl, strA40, and drugD strA alleles are indistinguishable since, in contrast with strA +, none of the three corresponding 30S subunits binds the drug in vitro (unpublished). In terms, however, of ribosomal functioning their response to streptomycin is quite different. This observation strengthens again the indication that the drug acts before assembly of 30S particles is completed. The programming effect of the drug is very conspicuous with the class of mutants carrying the drug-dependent 8trA allele, designated as phenotypically masked (3) and of which L190 is a revertant to independence. It involves not only suppression efficiency but also sensitivity to killing. Strain L190 is resistant to streptomycin and paromomycin used separately and when tested on cells grown in the absence of either drug. However, the cells are killed by the mixture streptomycin + paromomycin or when exposed to either drug after growth in the presence of the other. The pattern of misreading induced by streptomycin, paromomycin, or streptomycin + paromomycin is in remarkable agreement with that expected from the supposed programming effect. The L190 ribosomes with altered misreading are more stable than those of Li strA40 but they are still revertible to barely perceptible misreading levels after two precipitations with 1 M ammonium sulfate (8) . These widely different phenotypes obtained with the three strA alleles tested suggest that protein S12 plays a pivotal role in ribosomal assembly.
